These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates. Demanche C; Guillot J; Berthelemy M; Petitt T; Roux P; Wakefield AE Med Mycol; 2002 Jun; 40(3):315-8. PubMed ID: 12146763 [TBL] [Abstract][Full Text] [Related]
48. Pneumocystis jiroveci dihydropteroate synthase gene mutations at codon 171 but not at codons 55 or 57 detected in Germany. Riebold D; Fritzsche C; Lademann M; Bier A; Reisinger EC Clin Infect Dis; 2006 Feb; 42(4):582-3. PubMed ID: 16421813 [No Abstract] [Full Text] [Related]
49. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR. Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424 [TBL] [Abstract][Full Text] [Related]
50. Non specific PCR products using rat-derived Pneumocystis carinii dihydrofolate reductase gene-specific primers in DNA amplification of human respiratory samples. Ortona E; Margutti P; De Luca A; Peters SE; Wakefield AE; Tamburrini E; Mencarini P; Visconti E; Siracusano A Mol Cell Probes; 1996 Jun; 10(3):187-90. PubMed ID: 8799372 [TBL] [Abstract][Full Text] [Related]
51. Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast. Patel O; Karnik K; Macreadie IG FEMS Microbiol Lett; 2004 Jul; 236(2):301-5. PubMed ID: 15251211 [TBL] [Abstract][Full Text] [Related]
53. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation. Huang L; Morris AM; Beard CB J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054 [No Abstract] [Full Text] [Related]
54. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. Crothers K; Beard CB; Turner J; Groner G; Fox M; Morris A; Eiser S; Huang L AIDS; 2005 May; 19(8):801-5. PubMed ID: 15867494 [TBL] [Abstract][Full Text] [Related]
55. Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Calderón E; de la Horra C; Medrano FJ; López-Suárez A; Montes-Cano MA; Respaldiza N; Elvira-González J; Martín-Juan J; Bascuñana A; Varela JM Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):545-9. PubMed ID: 15175932 [TBL] [Abstract][Full Text] [Related]
56. [Genotypic resistance to sulfamide drugs among patients with Pneumocystis jiroveci pneumonia]. Calderón E; de la Horra C; Montes-Cano MA; Respaldiza N; Martín-Juan J; Varela JM Med Clin (Barc); 2004 May; 122(16):617-9. PubMed ID: 15142509 [TBL] [Abstract][Full Text] [Related]
57. PCR-RFLP analysis of the DHPS gene for the study of resistance of Pneumocystis carinii to sulpha drugs in patients with co-infection PCP/HIV. Costa MC; Helweg-Larsen J; Antunes F; Lungren B; Diogo J; Matos O J Eukaryot Microbiol; 2001; Suppl():148S-149S. PubMed ID: 11906035 [No Abstract] [Full Text] [Related]
58. Pneumocystis carinii: where are we now? Watson J J HIV Ther; 2002 Feb; 7(1):8-12. PubMed ID: 11956498 [TBL] [Abstract][Full Text] [Related]
60. Distribution of DHPS mutations among ITS subtypes of P. carinii f. sp. hominis. Meshnick SR; Hossler PA; Enger KS; Kazanjian P; Rest JS; Mindell D; Li B; Lee CH; Nimri LF; Carter JL; Beard CB; Huang L J Eukaryot Microbiol; 2001; Suppl():126S-128S. PubMed ID: 11906022 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]